13 patents currently held
30 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Aug 2027. from the record
Of the 30 now held by other companies, 24 were conveyed to MiMedx Group Inc. in the filing they arrived in, and 6 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
13
Ending by 2030
Aug 2027
Next term end
2
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.
Notable
Ends Oct 2029 · High confidence
Also notable
Ends Aug 2027 · High confidence
Improved Placental Tissue Grafts
US 8,323,701
The most cited patent in this portfolio, cited by 222 later US patents, top 5% of utility patents granted in 2012 in our data. Protection runs to 2029.
Placental Tissue Grafts
US 9,265,800
Cited by 27 later US patents, top 25% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2027. A terminal disclaimer caps this term to an earlier patent's.
Formerly held, still cited
Notable
Ends Feb 2032 · High confidence
Cited by 69 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2032. A terminal disclaimer caps this term to an earlier patent's.
now held by MiMedx Group, Inc.
Also notable
Ends Aug 2027 · High confidence
Cited by 64 later US patents, top 10% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
conveyed to MiMedx Group, Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Sep 1, 2027The maintenance fee for Placental Tissue Grafts (US 9,272,003) comes due Sep 1, 2027. Unpaid by Mar 1, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 23, 2026
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Improved Placental Tissue Grafts | 11 in force | to Oct 2029 |
| Placental Tissue Grafts | 2 in force | to Aug 2027 |
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,265,800 | Placental Tissue Grafts held by MiMedx Group, Inc. In force · High confidence | In force | High confidence | |
| US 9,272,005 | Placental Tissue Grafts held by MiMedx Group, Inc. In force · High confidence | In force | High confidence | |
| US 8,372,438 | Method for Inhibiting Adhesion Formation Using an Improved Placental Tissue Graft In force · High confidence | In force | High confidence | |
| US 8,372,439 | Method for Treating a Wound Using Improved Placental Tissue Graft In force · High confidence | In force | High confidence | |
| US 8,409,626 | Improved Placental Tissue Grafts In force · Medium confidence | In force | Medium confidence | |
| US 8,642,092 | Improved Placental Tissue Grafts In force · Medium confidence | In force | Medium confidence | |
| US 8,703,206 | Placental Tissue Grafts In force · High confidence | In force | High confidence | |
| US 8,703,207 | Improved Placental Tissue Grafts In force · Medium confidence | In force | Medium confidence | |
| US 8,709,493 | Placental Tissue Grafts In force · Medium confidence | In force | Medium confidence | |
| US 8,932,643 | Placental Tissue Grafts In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 13: 30 patents in force now held by others · 2 patents ended · 2 applications pending · 2 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
5 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed